{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:51:12Z","timestamp":1763563872375},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:00:00Z","timestamp":1402963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s13730-014-0132-3","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T12:41:38Z","timestamp":1403181698000},"page":"20-23","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Alendronate associated focal segmental glomerulosclerosis: a case report and review of the literature"],"prefix":"10.1007","volume":"4","author":[{"given":"Pranav S.","family":"Garimella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut G.","family":"Rennke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,17]]},"reference":[{"issue":"6","key":"132_CR1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","volume":"12","author":"GS Markowitz","year":"2001","unstructured":"Markowitz GS, et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol. 2001;12(6):1164\u201372.","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"132_CR2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1523-1755.2004.00426.x","volume":"65","author":"YM Barri","year":"2004","unstructured":"Barri YM, et al. Podocyte injury associated glomerulopathies induced by pamidronate. Kidney Int. 2004;65(2):634\u201341.","journal-title":"Kidney Int."},{"issue":"2","key":"132_CR3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2141.2002.03826.x","volume":"119","author":"R Desikan","year":"2002","unstructured":"Desikan R, et al. Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. Br J Haematol. 2002;119(2):496\u20139.","journal-title":"Br J Haematol."},{"issue":"6","key":"132_CR4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/j.ajkd.2006.02.189","volume":"47","author":"M Sauter","year":"2006","unstructured":"Sauter M, et al. Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept? Am J Kidney Dis. 2006;47(6):1075\u201380.","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"132_CR5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08998280.2007.11928298","volume":"20","author":"M Shreedhara","year":"2007","unstructured":"Shreedhara M, et al. Reversibility of pamidronate-associated glomerulosclerosis. Proc (Bayl Univ Med Cent). 2007;20(3):249\u201353.","journal-title":"Proc (Bayl Univ Med Cent)."},{"issue":"1","key":"132_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10157-008-0078-x","volume":"13","author":"N Miura","year":"2009","unstructured":"Miura N, et al. Massive proteinuria and acute renal failure after oral bisphosphonate (alendronate) administration in a patient with focal segmental glomerulosclerosis. Clin Exp Nephrol. 2009;13(1):85\u20138.","journal-title":"Clin Exp Nephrol."},{"issue":"10","key":"132_CR7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00198-007-0361-9","volume":"18","author":"J Pascual","year":"2007","unstructured":"Pascual J, et al. Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate. Osteoporos Int. 2007;18(10):1435\u20138.","journal-title":"Osteoporos Int."},{"issue":"1","key":"132_CR8","first-page":"91","volume":"2","author":"M Prikis","year":"2009","unstructured":"Prikis M, Gibson PC, Weise WJ. Alendronate-associated focal segmental glomerulosclerosis. NDT Plus. 2009;2(1):91\u20132.","journal-title":"NDT Plus."},{"issue":"7","key":"132_CR9","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00198-011-1836-2","volume":"23","author":"M Yilmaz","year":"2012","unstructured":"Yilmaz M, et al. Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis. Osteoporos Int. 2012;23(7):2059\u201362.","journal-title":"Osteoporos Int."},{"issue":"10","key":"132_CR10","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/ndt\/17.10.1856-a","volume":"17","author":"JD Stratton","year":"2002","unstructured":"Stratton JD, Warwicker P. Relapse of nephrotic syndrome triggered by biphosphonates. Nephrol Dial Transplant. 2002;17(10):1856\u20137.","journal-title":"Nephrol Dial Transplant."},{"issue":"11","key":"132_CR11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","volume":"74","author":"MA Perazella","year":"2008","unstructured":"Perazella MA, Markowitz GS. Bisphosphonate nephrotoxicity. Kidney Int. 2008;74(11):1385\u201393.","journal-title":"Kidney Int."},{"issue":"1","key":"132_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.V10151","volume":"10","author":"L Barisoni","year":"1999","unstructured":"Barisoni L, et al. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999;10(1):51\u201361.","journal-title":"J Am Soc Nephrol."},{"issue":"20 Pt 2","key":"132_CR13","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs AJ, et al. Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res. 2006;12(20 Pt 2):6222s\u201330s.","journal-title":"Clin Cancer Res."},{"issue":"12 Suppl","key":"132_CR14","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","volume":"88","author":"MJ Rogers","year":"2000","unstructured":"Rogers MJ, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer. 2000;88(12 Suppl):2961\u201378.","journal-title":"Cancer."},{"issue":"23","key":"132_CR15","first-page":"5294","volume":"58","author":"CM Shipman","year":"1998","unstructured":"Shipman CM, et al. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Cancer Res. 1998;58(23):5294\u20137.","journal-title":"Cancer Res."},{"issue":"10","key":"132_CR16","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1681\/ASN.2006030225","volume":"17","author":"M Albaqumi","year":"2006","unstructured":"Albaqumi M, et al. Collapsing glomerulopathy. J Am Soc Nephrol. 2006;17(10):2854\u201363.","journal-title":"J Am Soc Nephrol."}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0132-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-014-0132-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0132-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T21:28:43Z","timestamp":1649453323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-014-0132-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,17]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1007\/s13730-014-0132-3","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,17]]}}}